H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013

Cost Estimate
February 21, 2013

As reported by the Senate Committee on Health, Education, Labor, and Pensions on February 14, 2013

H.R. 307 would amend the Public Health Service Act and the United States Code to authorize funding for certain activities carried out by the Departments of Health and Human Services (HHS) and Veterans Affairs (VA) that would support the readiness of the public health system to address public health and medical emergencies.

Based on information provided by HHS and VA, CBO estimates that implementing the act would cost about $11 billion over the 2014-2018 period, assuming the appropriation of the authorized amounts. The Consolidated Appropriations Act, 2012, included funding totaling about $2 billion in fiscal year 2012 for activities similar to those that would be authorized by H.R. 307. CBO assumes that amounts appropriated through the Continuing Appropriations Resolution, 2013, for those activities are similar to 2012 levels.

H.R. 307 also would change the terms for Project Bioshield contracts, which would result in a change in direct spending. Assuming H.R. 307 is enacted this spring, it would decrease direct spending by $58 million over the 2013-2018 period, but would result in no net change in direct spending over the 2013-2023 period. Because the legislation would affect direct spending, pay-as-you-go procedures apply. Enacting H.R. 307 would not affect revenues.

H.R. 307 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act (UMRA).